IGC Pharma, Inc.

IGC XASE • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

28M

Short interest (Jul 15)

0.4%

Net Short (Jul 27 ): 0.0%

Borrow Fee

0.51%

↑ 14.7%

Available Shares

↑ 5.5%

Price Chart

Company Overview

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Company Info

Exchange: XASE

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001326205

Asset Type: CS

Market Data

Market Cap: $27,552,668

Employees: 70

Status: Active

Short Interest

Current Borrow Fee 0.51%

Range: 0.51% - 0.78%

Available Shares 6M

Range: 5.4M - 5.5M

Recent Changes

Fee Change: ↑ 14.4%

Available Change: ↑ 3.8%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime